Journal Article10.1002/JAT.4144
Plasma miR-218a-5p as a biomarker for acute cholestatic liver injury in rats and investigation of its pathophysiological roles
3
TL;DR: In this paper, the authors investigated whether miRNAs increase in a severity-dependent manner and to elucidate their pathophysiological roles in cholestasis, and they found that miR-218a-5p levels increased in a dosedependent manner in choline rats but not in hepatocellular injury.
read more
Abstract: MicroRNAs (miRNA) have received considerable attention as potential biomarkers for drug-induced liver injury. We recently reported that the plasma levels of miR-143-3p and miR-218a-5p increased in severe cholestasis in rats. This study aimed to investigate whether these miRNAs increase in a severity-dependent manner and to elucidate their pathophysiological roles in cholestasis. Male Sprague-Dawley rats were orally administered different doses of α-naphthylisothiocyanate or 4,4-methylenedianiline to induce acute cholestasis. They were also orally administered acetaminophen or thioacetamide to induce hepatocellular injury. We found that plasma miR-143-3p and miR-218a-5p levels increased in a dose-dependent manner in cholestatic rats but not in hepatocellular injury. Bioinformatic analysis provided putative target genes of hsa-miR-218-5p, rno-miR-218a-5p, and mmu-miR-218-5p, among which GNAI2, PPP1CB, and PPP2R5A were experimentally validated as their direct target genes in human cholangiocyte line MMNK-1. Proliferation of MMNK-1 cells was significantly suppressed after overexpression of miR-218-5p and transduction of siRNAs for GNAI2, PPP1CB, and PPP2R5A. In the cholestatic livers of rats, Ppp1cb and Ppp2r5a expression levels decreased, whereas Gnai2 expression levels increased compared with those in vehicle-treated rats, suggesting that Ppp1cb and Ppp2r5a may be under the control of miR-218a-5p in vivo. In conclusion, our data suggest that miR-218(a)-5p is involved in the suppression of cholangiocyte proliferation by inhibiting the expression of PPP1CB and PPP2R5A, thereby contributing to the pathogenesis of cholestasis; and miR-218a-5p leaks into the plasma probably from damaged cholangiocytes in a severity-dependent manner in rats. Therefore, miR-218a-5p overexpression could be one of the underlying mechanisms of acute cholestatic liver injury in rats.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Unraveling the actin cytoskeleton in the malignant transformation of cholangiocyte biology
TL;DR: In this paper , the authors highlight the importance of the actin cytoskeleton itself as cause for aberrant signaling and in promoting tumorigenic phenotypes, and highlight the impact of aberrant signalling networks on the ACT and its rearrangement as potential cause for CCA.
The role of microRNA and long non-coding RNA in cholestatic liver diseases
Yudian Zhang,Ying Liu,Weiguang Huo,Lin He,Bowen Li,Hui-Yun Wang,Fanyin Meng,Chaojun Duan,Bingru Zhou,Jia‐Zhu Wu,Rong Chen,Juan Xing,Ying Wan +12 more
TL;DR: MicroRNA and long non-coding RNA play a role in cholestatic liver diseases. Their involvement in the disease progression needs further investigation to develop effective therapies.
miR-218-5p promotes hepatic lipogenesis through targeting Elovl5 in non-alcoholic fatty liver disease
Guanlin Wu,Yan Zhang,Bo Liang,Lianhong Yin,Meng Gao,Han Zhang,Youwei Xu,Xu Han,Qi Yan,Fang Liu,Lina Xu +10 more
TL;DR: This study reveals that miR-218-5p promotes hepatic lipogenesis in non-alcoholic fatty liver disease (NAFLD) by targeting Elovl5, a key regulator of fatty acid synthesis, thereby accelerating NAFLD development and providing a new therapeutic target.
References
Most mammalian mRNAs are conserved targets of microRNAs
TL;DR: This work overhauled its tool for finding preferential conservation of sequence motifs and applied it to the analysis of human 3'UTRs, increasing by nearly threefold the detected number of preferentially conserved miRNA target sites.
Predicting effective microRNA target sites in mammalian mRNAs
TL;DR: It is shown that recently reported non-canonical sites do not mediate repression despite binding the miRNA, which indicates that the vast majority of functional sites are canonical.
Human MicroRNA Targets
Bino John,Anton J. Enright,Anton J. Enright,Alexei A. Aravin,Thomas Tuschl,Chris Sander,Debora S. Marks +6 more
TL;DR: This work has predicted target sites on the 3′ untranslated regions of human gene transcripts for all currently known 218 mammalian miRNAs to facilitate focused experiments and suggests that miRNA genes, which are about 1% of all human genes, regulate protein production for 10% or more of allhuman genes.
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma
Jason D. Arroyo,John R. Chevillet,Evan M. Kroh,Ingrid K. Ruf,Colin C. Pritchard,Donald F. Gibson,Patrick S. Mitchell,Christopher F. Bennett,Era L. Pogosova-Agadjanyan,Derek L. Stirewalt,Jonathan F. Tait,Muneesh Tewari +11 more
TL;DR: Identification of extracellular Ago2–miRNA complexes in plasma raises the possibility that cells release a functional miRNA-induced silencing complex into the circulation, and reveals two populations of circulating miRNAs and suggest that circulating Ago2 complexes are a mechanism responsible for the stability of plasma mi RNAs.
3.2K
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
TL;DR: Evidence that high-density lipoprotein (HDL) transports endogenous miRNAs and delivers them to recipient cells with functional targeting capabilities is presented, indicating that HDL participates in a mechanism of intercellular communication involving the transport and delivery of miRNA.